Cardinal Health Latest News

New tool is designed to help pharmacies navigate state-by-state interchangeability laws for the FDA’s new regulatory designation Cardinal Health has created an interactive tool that provides...

Change has been the one constant in nuclear medicine from the beginning, with the steady arrival of new radiopharmaceuticals, new technologies and an evolving regulatory environment. Today, as...

Our chief strategy officer, Michele Holcomb, spoke with Forbes about the deep connection between diversity, equity and inclusion (DE&I) and innovation. “My view of innovation was formed early in...

In December 2020, the FDA announced that a new radioactive diagnostic agent, Gallium 68 (Ga-68) PSMA-11, could be prescribed and administered to patients with suspected prostate cancer metastasis...

Last year, a critical need for life-saving blood and plasma donations arose with two major complications: an extraordinary decrease in blood donations due to the COVID-19 pandemic, and...